All News

Progression-free survival improved with Zejula compared with placebo in patients with BRCA-mutated ovarian cancer with no new safety signals.

The data, according to one of the study’s authors, are critical in understanding the disparities in prostate cancer.

Adding Opdivo to treatment with Yervoy or chemotherapy improved survival, compared with chemotherapy alone in patients with unresectable and advanced esophageal cancer.

Some patients with early HER2-negative breast cancer at high risk for disease recurrence achieved meaningful benefit with Lynparza after receiving standard of care therapies, such as surgery or chemotherapy.

The addition of a novel drug to the chemotherapies gemcitabine and cisplatin significantly improved a survival outcome in patients with a rare form of head and neck cancer, compared with chemotherapy alone.

Treatment with chemotherapy following the standard chemoradiation treatment failed to improve multiple survival outcomes in women with locally advanced cervical cancer.

Treatment with Keytruda following surgery was associated with a significant reduction in the risk of disease recurrence or death compared with placebo in patients with clear cell renal cell carcinoma.

The addition of an investigational therapy to standard-of-care treatment was associated with a median overall survival of 15.3 months in patients with progressive PSMA-positive metastatic castration-resistant prostate cancer.

A young cancer survivor describes the difficulty of seeing others in his age group living out their dreams.

From a cancer survivor who cleans up trash and turns it into artwork to the inaugural National Black Family Cancer Awareness week, here’s what’s happening in the cancer landscape this week.

It is important to help people feel more confident as they face many decisions during their cancer journey and provide them with resources to show them that they don’t have to face the disease alone.

Combination therapy with Aliqopa and rituximab improved progression-free survival in patients with relapsed indolent non-Hodgkin lymphoma.

A recent study found that among a substantial proportion of premenopausal women with breast cancer, endocrine therapy decisions and fertility concerns are interwoven.

A patient with metastatic breast cancer describes how the right words can offer hope to patients and the wrong ones can haunt them forever.

In this episode of the “CURE® Talks Cancer” podcast, breast cancer survivor Tomika Bryant discusses her cancer journey, advocacy work and how blogging helped her get through treatment.

The Food and Drug Administration has had a busy couple of weeks, approving several agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.

Patients with relapsed/refractory acute lymphoblastic leukemia may have prolonged survival with Blincyto, especially among those who undergo hematopoietic stem cell transplantation.

The Food and Drug Administration’s priority review will focus on the combination of plinabulin plus granulocyte colony-stimulating factor for the prevention of chemotherapy-induced neutropenia.

A senior cancer survivor shares her experiences with post-cancer finances and offers some advice to others in the same situation.

Patients with cancer experienced higher levels of loneliness, isolation and symptom burden due to social distancing procedures for COVID-19, according to a recent study.

Sociodemographic factors such as race, marital status, health status and age all played a role in understanding which patients and survivors are receiving informal care from a family member or friend during and after treatment.

On social media, CURE® recently asked its readers to share what was the most surprising thing that changed in their life since receiving a cancer diagnosis. Here’s what they shared.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for May 2021.

A survivor of fibrosarcoma shares his journey through treatment and how he learned to build strength and confidence after the ordeal physically changed his face.

A patient describes the connection that she has with a senior research nurse at the institution where she has been enrolled in a clinical trial since 2019.

A patient with multiple myeloma nominates a nurse who is the welcoming face patients sometimes need when going for doctor’s visits.

A patient describes her experience with a nurse shortly after her breast cancer surgery, which involved relocation to another facility.

A radiation oncology nurse takes the time to educate both patients and her clinical team to better manage side effects during therapy.

A mother describes how lonely she feels as the caregiver of an adult child with cancer.

A patient details the compassionate support that she received from an oncology nurse while receiving back-to-back treatments for cancer.